Andrew J Foy1,2, Sanket S Dhruva3, Brandon Peterson1, John M Mandrola4, Daniel J Morgan5, Rita F Redberg6,7. 1. Department of Medicine, Penn State College of Medicine, Hershey, Pennsylvania. 2. Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania. 3. Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut. 4. Louisville Cardiology Group, Baptist Health, Louisville, Kentucky. 5. Department of Medicine, University of Maryland School of Medicine, Baltimore. 6. Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco. 7. Editor.
Abstract
Importance: Coronary computed tomography angiography (CCTA) is a new approach for the diagnosis of anatomical coronary artery disease (CAD), but it is unclear how CCTA performs compared with the standard approach of functional stress testing. Objective: To compare the clinical effectiveness of CCTA with that of functional stress testing for patients with suspected CAD. Data Sources: A systematic literature search was conducted in PubMed and MEDLINE for English-language randomized clinical trials of CCTA published from January 1, 2000, to July 10, 2016. Study Selection: Researchers selected randomized clinical trials that compared a primary strategy of CCTA with that of functional stress testing for patients with suspected CAD and reported data on patient clinical events and changes in therapy. Data Extraction and Synthesis: Two reviewers independently extracted data from and assessed the quality of the trials. This analysis followed the PRISMA statement for reporting systematic reviews and meta-analyses and used the Cochrane Collaboration's tool for assessing risk of bias in randomized trials. The Mantel-Haenszel method was used to conduct the primary analysis. Summary relative risks were calculated with a random-effects model. Main Outcomes and Measures: The outcomes of interest were all-cause mortality, cardiac hospitalization, myocardial infarction, invasive coronary angiography, coronary revascularization, new CAD diagnoses, and change in prescription for aspirin and statins. Results: Thirteen trials were included, with 10 315 patients in the CCTA arm and 9777 patients in the functional stress testing arm who were followed up for a mean duration of 18 months. There were no statistically significant differences between CCTA and functional stress testing in death (1.0% vs 1.1%; risk ratio [RR], 0.93; 95% CI, 0.71-1.21) or cardiac hospitalization (2.7% vs 2.7%; RR, 0.98; 95% CI, 0.79-1.21), but CCTA was associated with a reduction in the incidence of myocardial infarction (0.7% vs 1.1%; RR, 0.71; 95% CI, 0.53-0.96). Patients undergoing CCTA were significantly more likely to undergo invasive coronary angiography (11.7% vs 9.1%; RR, 1.33; 95% CI, 1.12-1.59) and revascularization (7.2% vs 4.5%; RR, 1.86; 95% CI, 1.43-2.43). They were also more likely to receive a diagnosis of new CAD and to have initiated aspirin or statin therapy. Conclusions and Relevance: Compared with functional stress testing, CCTA is associated with a reduced incidence of myocardial infarction but an increased incidence of invasive coronary angiography, revascularization, CAD diagnoses, and new prescriptions for aspirin and statins. Despite these differences, CCTA is not associated with a reduction in mortality or cardiac hospitalizations.
Importance: Coronary computed tomography angiography (CCTA) is a new approach for the diagnosis of anatomical coronary artery disease (CAD), but it is unclear how CCTA performs compared with the standard approach of functional stress testing. Objective: To compare the clinical effectiveness of CCTA with that of functional stress testing for patients with suspected CAD. Data Sources: A systematic literature search was conducted in PubMed and MEDLINE for English-language randomized clinical trials of CCTA published from January 1, 2000, to July 10, 2016. Study Selection: Researchers selected randomized clinical trials that compared a primary strategy of CCTA with that of functional stress testing for patients with suspected CAD and reported data on patient clinical events and changes in therapy. Data Extraction and Synthesis: Two reviewers independently extracted data from and assessed the quality of the trials. This analysis followed the PRISMA statement for reporting systematic reviews and meta-analyses and used the Cochrane Collaboration's tool for assessing risk of bias in randomized trials. The Mantel-Haenszel method was used to conduct the primary analysis. Summary relative risks were calculated with a random-effects model. Main Outcomes and Measures: The outcomes of interest were all-cause mortality, cardiac hospitalization, myocardial infarction, invasive coronary angiography, coronary revascularization, new CAD diagnoses, and change in prescription for aspirin and statins. Results: Thirteen trials were included, with 10 315 patients in the CCTA arm and 9777 patients in the functional stress testing arm who were followed up for a mean duration of 18 months. There were no statistically significant differences between CCTA and functional stress testing in death (1.0% vs 1.1%; risk ratio [RR], 0.93; 95% CI, 0.71-1.21) or cardiac hospitalization (2.7% vs 2.7%; RR, 0.98; 95% CI, 0.79-1.21), but CCTA was associated with a reduction in the incidence of myocardial infarction (0.7% vs 1.1%; RR, 0.71; 95% CI, 0.53-0.96). Patients undergoing CCTA were significantly more likely to undergo invasive coronary angiography (11.7% vs 9.1%; RR, 1.33; 95% CI, 1.12-1.59) and revascularization (7.2% vs 4.5%; RR, 1.86; 95% CI, 1.43-2.43). They were also more likely to receive a diagnosis of new CAD and to have initiated aspirin or statin therapy. Conclusions and Relevance: Compared with functional stress testing, CCTA is associated with a reduced incidence of myocardial infarction but an increased incidence of invasive coronary angiography, revascularization, CAD diagnoses, and new prescriptions for aspirin and statins. Despite these differences, CCTA is not associated with a reduction in mortality or cardiac hospitalizations.
Authors: Haris Riaz; Sajjad Raza; Muhammad Shahzeb Khan; Irbaz Bin Riaz; Richard A Krasuski Journal: Am J Cardiol Date: 2015-10-09 Impact factor: 2.778
Authors: Harold I Litt; Constantine Gatsonis; Brad Snyder; Harjit Singh; Chadwick D Miller; Daniel W Entrikin; James M Leaming; Laurence J Gavin; Charissa B Pacella; Judd E Hollander Journal: N Engl J Med Date: 2012-03-26 Impact factor: 91.245
Authors: Adam H Miller; Paul E Pepe; Ron Peshock; Rafia Bhore; Clyde C Yancy; Lei Xuan; Margarita M Miller; Gisselle R Huet; Clayton Trimmer; Rene Davis; Rebecca Chason; Micheal T Kashner Journal: Acad Emerg Med Date: 2011-05 Impact factor: 3.451
Authors: James K Min; Sunaina Koduru; Allison M Dunning; Jason H Cole; Jerome L Hines; Dawn Greenwell; Cathie Biga; Gayle Fanning; Troy M LaBounty; Millie Gomez; James M Horowitz; Martin Hadimitzsky; Jorg Hausleiter; Tracy Q Callister; Alan R Rosanski; Leslee J Shaw; Daniel S Berman; Fay Y Lin Journal: J Cardiovasc Comput Tomogr Date: 2012-06-11
Authors: Joseph B Muhlestein; Donald L Lappé; Joao A C Lima; Boaz D Rosen; Heidi T May; Stacey Knight; David A Bluemke; Steven R Towner; Viet Le; Tami L Bair; Andrea L Vavere; Jeffrey L Anderson Journal: JAMA Date: 2014-12-03 Impact factor: 56.272
Authors: James A Goldstein; Michael J Gallagher; William W O'Neill; Michael A Ross; Brian J O'Neil; Gilbert L Raff Journal: J Am Coll Cardiol Date: 2007-02-12 Impact factor: 24.094
Authors: Georges El-Hayek; Alexandre Benjo; Seth Uretsky; Mouaz Al-Mallah; Randy Cohen; Daniel Bamira; Patricia Chavez; Francisco Nascimento; Orlando Santana; Rajan Patel; João L Cavalcante Journal: Int J Cardiol Date: 2014-09-22 Impact factor: 4.164
Authors: Edward Hulten; Christopher Pickett; Marcio Sommer Bittencourt; Todd C Villines; Sara Petrillo; Marcelo F Di Carli; Ron Blankstein Journal: J Am Coll Cardiol Date: 2013-02-06 Impact factor: 24.094
Authors: Márcio Sommer Bittencourt; Edward A Hulten; Venkatesh L Murthy; Michael Cheezum; Carlos E Rochitte; Marcelo F Di Carli; Ron Blankstein Journal: Circ Cardiovasc Imaging Date: 2016-04 Impact factor: 7.792
Authors: Michael C Honigberg; Bradley S Lander; Vinit Baliyan; Maeve Jones-O'Connor; Emma W Healy; Jan-Erik Scholtz; John T Nagurney; Udo Hoffmann; Brian B Ghoshhajra; Pradeep Natarajan Journal: JACC Cardiovasc Imaging Date: 2019-07-17
Authors: Luiz Eduardo Mastrocola; Barbara Juarez Amorim; João Vicente Vitola; Simone Cristina Soares Brandão; Gabriel Blacher Grossman; Ronaldo de Souza Leão Lima; Rafael Willain Lopes; William Azem Chalela; Lara Cristiane Terra Ferreira Carreira; José Roberto Nolasco de Araújo; Cláudio Tinoco Mesquita; José Claudio Meneghetti Journal: Arq Bras Cardiol Date: 2020-02 Impact factor: 2.000
Authors: Inge J van den Hoogen; Alexander R van Rosendael; Fay Y Lin; Jeroen J Bax; Leslee J Shaw; James K Min Journal: Curr Cardiovasc Imaging Rep Date: 2019-05-14
Authors: Evangelos K Oikonomou; David Van Dijk; Helen Parise; Marc A Suchard; James de Lemos; Charalambos Antoniades; Eric J Velazquez; Edward J Miller; Rohan Khera Journal: Eur Heart J Date: 2021-07-08 Impact factor: 29.983